The multiplex real-time PCR assay enables the simultaneous detection of Trichomonas vaginalis or Mycoplasma genitalium in urine and vaginal samples.
BioGx now offers 11 CE-marked infectious disease tests that run on Becton Dickinson's BD Max platform.
IncellDx HPV OncoTect 3Dx system combines the quantification of oncogene mRNA overexpression, proliferation, and aneuploidy in one high-throughput assay, according to the firm.
The company submitted the platform and gastrointestinal panel to the US Food and Drug Administration for clearance earlier this year.
Amplidiag CarbaR+MCR detects the main carbapenemase-producing organisms and colistin resistance markers. Novidiag Bacterial GE+ identifies the most common enteric pathogens.
The test cartridge runs on the company's Unyvero platform and covers 103 diagnostic targets for various pathogens and markers of antibiotic resistance.
The firm says its Olerup QType test is available on both Roche and Applied Biosystems platforms.
The firm has launched a multiplex real-time PCR assay that detects HPV 16, HPV 18, and a pool of 12 other high-risk HPV subtypes.
The company hopes that meeting the needs of a more decentralized testing model will increase access to its products for European women with breast cancer.
The Artus T. vaginalis QS-RGQ kit is designed for the qualitative detection of Trichomonas vaginalis DNA purified from clinician-collected patient samples.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.
NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.